• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

(BAY-1143572)

1

Identification

BAY-1143572 BAY-1143572
Name BAY-1143572
Formula C18H18FN5O2S
MW 387.43
CAS No.
EINECS
Smiles N=[[email protected]](CC1=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=CC=C1)(C)=O
Synonyms
InChI InChI=1S/C18H18FN5O2S/c1-26-16-9-13(19)6-7-15(16)17-21-11-22-18(24-17)23-14-5-3-4-12(8-14)10-27(2,20)25/h3-9,11,20H,10H2,1-2H3,(H,21,22,23,24)/t27-/m1/s1
2

Introduction

BAY-1143572 is a potent and highly selective, oral PTEFb/CDK9 inhibitor. BAY-1143572 inhibits CDK9/CycT1 with an IC50 of 13 nM.

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB100159993

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways Cell Cycle/DNA Damage
Target CDK
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of BAY-1143572

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
AMEDCHEM CHINA
10

Related Products

Other Forms of

Name CAS No Formula MW

Recommended Compounds in CDK

Name CAS No Formula MW
LY2857785 1619903-54-6 C26H36N6O 448.6
THZ2 1604810-84-5 C31H28ClN7O2 566.0527
Palbociclib (isethionate) 827022-33-3 C26H35N7O6S 573.66
CDK9-IN-6 1391855-95-0 C27H37ClN6O2 513.07468
ML167 1285702-20-6 C19H17N3O3 335.36
AMG 925 1401033-86-0 C26H29N7O2 471.55
LDC000067 1073485-20-7 C18H18N4O3S 370.43
LEE011 (succinate hydrate) 1374639-79-8 C27H38N8O6X 570.64
LEE011 (succinate) 1374639-75-4 C27H36N8O5 552.63
LEE011 (hydrochloride) 1211443-80-9 C23H31ClN8O 471.0
LEE011 1211441-98-3 C23H30N8O 434.54
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 333.77
Wogonin 632-85-9 C16H12O5 284.26
1-NM-PP1 221244-14-0 C20H21N5 331.41
WHI-P180 211555-08-7 C16H15N3O3 297.31
THZ1 1604810-83-4 C31H28ClN7O2 566.05
Senexin A 1366002-50-7 C17H14N4 274.32
CDK4-IN-1 1256963-02-6 C22H29ClN8 440.97
Palbociclib (hydrochloride) 827022-32-2 C24H30ClN7O2 483.99
Purvalanol B 212844-54-7 C20H25ClN6O3 432.9

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

BAY-1143572

Tags: buy BAY-1143572 IC50 | BAY-1143572 price | BAY-1143572 cost | BAY-1143572 solubility | BAY-1143572 purchase | BAY-1143572 manufacturer | BAY-1143572 research buy | BAY-1143572 order | BAY-1143572 MSDS | BAY-1143572 chemical structure | BAY-1143572 Storage condition | BAY-1143572 molecular weight | BAY-1143572 mw | BAY-1143572 datasheet | BAY-1143572 supplier | BAY-1143572 cell line | BAY-1143572 NMR | BAY-1143572 MS | BAY-1143572 IR | BAY-1143572 solubility | BAY-1143572 Safe information | BAY-1143572 Qc and Spectral Information | BAY-1143572 Clinical Information | BAY-1143572 Clinical Trial | BAY-1143572 Route of Synthesis | BAY-1143572 storage condition | BAY-1143572 diseases and conditions | BAY-1143572 flash point | BAY-1143572 boiling point | BAY-1143572 melting point | BAY-1143572 storage condition | BAY-1143572 brand